Application Nr Approved Date Route Status External Links
BLA021018 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Humalog Mix50/50 Is Indicated To Improve Glycemic Control In Patients With Diabetes Mellitus. Humalog ® Mix50/50™ Is A Mixture Of Insulin Lispro Protamine, An Intermediate-Acting Human Insulin Analog, And Insulin Lispro, A Rapid-Acting Human Insulin Analog Indicated To Improve Glycemic Control In Patients With Diabetes Mellitus. ( 1 ) Limitations Of Use: The Proportions Of Rapid-Acting And Intermediate-Acting Insulins Are Fixed And Do Not Allow For Basal Versus Prandial Dose Adjustments. ( 1 ) Limitations Of Use: The Proportions Of Rapid-Acting And Intermediate-Acting Insulins In Humalog Mix50/50 Are Fixed And Do Not Allow For Basal Versus Prandial Dose Adjustments.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Lispro

Comments